Enimmune Corporation (TPEX:6564)
13.60
-1.10 (-7.48%)
Nov 20, 2026, 1:50 PM CST
Enimmune Market Cap
Enimmune has a market cap or net worth of 981.02 million as of November 20, 2026. It is the 33,399th most valuable company in the world and the 1,977th biggest in Taiwan. Its market cap has decreased by 33.33% in one year.
Market Cap
981.02M
Enterprise Value
968.15M
Revenue
53.45M
Global Rank
Country Rank
#1,977 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 18, 2018, Enimmune's market cap has decreased from 1.33B to 981.02M, a decrease of -26.15%. That is a compound annual growth rate of -3.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.05B | -29.61% |
| Dec 31, 2025 | 1.49B | -17.27% |
| Dec 31, 2024 | 1.80B | -27.21% |
| Dec 29, 2023 | 2.47B | -38.63% |
| Dec 30, 2022 | 4.02B | 69.85% |
| Dec 30, 2021 | 2.37B | -11.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.20B |
| Advagene Biopharma | 1.19B |
| Abnova (Taiwan) | 1.12B |
| LabTurbo Biotech | 1.04B |
| Bio Preventive Medicine | 1.01B |
| Level Biotechnology | 937.89M |
| BiOptic | 893.39M |
| TCI GENE | 873.13M |